DK0975235T3 - Ernæringssammensætninger indeholdende oligosaccharider - Google Patents

Ernæringssammensætninger indeholdende oligosaccharider

Info

Publication number: DK0975235T3
Authority: DK; Denmark
Prior art keywords: lacto; compositions containing; nutritional compositions; containing oligosaccharides; fucopentaose
Prior art date: 1997-03-31

Application number

DK98912118T

Other languages

English (en)

Other versions

DK0975235T4 (da

Inventor

Pedro A Prieto

Stephen J Kirchner

Renee M Erney

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-31

Filing date

1998-03-30

Publication date

2006-10-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25253688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0975235(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-03-30 Application filed by Abbott Lab filed Critical Abbott Lab

2006-10-02 Publication of DK0975235T3 publication Critical patent/DK0975235T3/da

2014-03-31 Application granted granted Critical

2014-03-31 Publication of DK0975235T4 publication Critical patent/DK0975235T4/da

Links

239000000203 mixture Substances 0.000 title abstract 2
235000016709 nutrition Nutrition 0.000 title abstract 2
229920001542 oligosaccharide Polymers 0.000 title abstract 2
150000002482 oligosaccharides Chemical class 0.000 title abstract 2
229940062827 2'-fucosyllactose Drugs 0.000 abstract 1
HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 abstract 1
HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 abstract 1
AUNPEJDACLEKSC-ZAYDSPBTSA-N 3-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O AUNPEJDACLEKSC-ZAYDSPBTSA-N 0.000 abstract 1
WJPIUUDKRHCAEL-UHFFFAOYSA-N 3FL Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(O)C1O WJPIUUDKRHCAEL-UHFFFAOYSA-N 0.000 abstract 1
TVVLIFCVJJSLBL-SEHWTJTBSA-N Lacto-N-fucopentaose V Chemical compound O[C@H]1C(O)C(O)[C@H](C)O[C@H]1OC([C@@H](O)C=O)[C@@H](C(O)CO)O[C@H]1[C@H](O)[C@@H](OC2[C@@H](C(OC3[C@@H](C(O)C(O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@@H](CO)O1 TVVLIFCVJJSLBL-SEHWTJTBSA-N 0.000 abstract 1
LKOHREGGXUJGKC-UHFFFAOYSA-N Lactodifucotetraose Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)OC2CO)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O LKOHREGGXUJGKC-UHFFFAOYSA-N 0.000 abstract 1
AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 abstract 1
SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 abstract 1
FZIVHOUANIQOMU-YIHIYSSUSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@H](O)[C@@H]1O FZIVHOUANIQOMU-YIHIYSSUSA-N 0.000 abstract 1
LKOHREGGXUJGKC-GXSKDVPZSA-N alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-Glcp Chemical compound C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O LKOHREGGXUJGKC-GXSKDVPZSA-N 0.000 abstract 1
CMQZRJBJDCVIEY-JEOLMMCMSA-N alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)[C@@H]1NC(C)=O CMQZRJBJDCVIEY-JEOLMMCMSA-N 0.000 abstract 1
DUKURNFHYQXCJG-JEOLMMCMSA-N alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)O[C@@H]1CO DUKURNFHYQXCJG-JEOLMMCMSA-N 0.000 abstract 1
AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
FZIVHOUANIQOMU-UHFFFAOYSA-N lacto-N-fucopentaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)OC(CO)C2O)NC(C)=O)OC(CO)C(O)C1O FZIVHOUANIQOMU-UHFFFAOYSA-N 0.000 abstract 1
FKADDOYBRRMBPP-UHFFFAOYSA-N lacto-N-fucopentaose II Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C2O)O)OC1CO FKADDOYBRRMBPP-UHFFFAOYSA-N 0.000 abstract 1
CMQZRJBJDCVIEY-UHFFFAOYSA-N lacto-N-fucopentaose III Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C1NC(C)=O CMQZRJBJDCVIEY-UHFFFAOYSA-N 0.000 abstract 1
IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 abstract 1
USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 abstract 1
229940062780 lacto-n-neotetraose Drugs 0.000 abstract 1
RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Polymers & Plastics (AREA)
Nutrition Science (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Pediatric Medicine (AREA)
Molecular Biology (AREA)
Mycology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Dairy Products (AREA)
Jellies, Jams, And Syrups (AREA)
Saccharide Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK98912118.1T 1997-03-31 1998-03-30 Ernæringssammensætninger indeholdende oligosaccharider DK0975235T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/829,157 US6045854A (en)	1997-03-31	1997-03-31	Nutritional formulations containing oligosaccharides
PCT/US1998/006216 WO1998043494A1 (en)	1997-03-31	1998-03-30	Nutritional formulations containing oligosaccharides

Publications (2)

Publication Number	Publication Date
DK0975235T3 true DK0975235T3 (da)	2006-10-02
DK0975235T4 DK0975235T4 (da)	2014-03-31

Family

ID=25253688

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98912118.1T DK0975235T4 (da)	1997-03-31	1998-03-30	Ernæringssammensætninger indeholdende oligosaccharider

Country Status (12)

Country	Link
US (2)	US6045854A (da)
EP (1)	EP0975235B2 (da)
JP (2)	JP4863236B2 (da)
AT (1)	ATE326862T1 (da)
CA (1)	CA2285065C (da)
DE (1)	DE69834633T3 (da)
DK (1)	DK0975235T4 (da)
ES (1)	ES2265161T5 (da)
MX (1)	MX210206B (da)
NO (1)	NO315682B1 (da)
PT (1)	PT975235E (da)
WO (1)	WO1998043494A1 (da)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19701382A1 (de) *	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
US6329170B1 (en) *	1999-04-23	2001-12-11	Northwest Hospital	Nucleic acids and proteins of a rat ganglioside GM1-specific α1→2fucosyltransferase and uses thereof
DE19958985A1 (de) *	1999-12-07	2001-06-13	Nutricia Nv	Oligosaccharidmischung
EP1062873A1 (en) *	1999-12-13	2000-12-27	N.V. Nutricia	Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
US6864242B2 (en)	2001-03-05	2005-03-08	Stephen P. Ernest	Enteral formulation
DE10147100A1 (de) *	2001-09-25	2003-04-17	Numico Res B V	Antiinfektive Kohlenhydrate
DE10204000A1 (de) *	2002-02-01	2003-08-14	Nutricia Nv	Sialysierte Kohlenhydrate
AU2003273206B2 (en) *	2002-05-31	2009-08-20	Children's Hospital Medical Center	Method, composition and kit for antigenic binding of Norwalk-Like viruses
US7977098B2 (en) *	2002-05-31	2011-07-12	Children's Hospital Medical Center	Antigenic binding patterns of norovirus to human histo-blood group antigens
DK1531832T3 (da) *	2002-06-28	2009-07-27	Glykos Finland Oy	Terapeutiske sammensætninger til anvendelse ved profylakse eller behandling af diarré
CA2530170A1 (en) *	2003-06-24	2005-01-06	University Of Kansas Medical Center	Infant formula
EP2497478A3 (en) *	2003-12-05	2012-11-07	Children's Hospital Medical Center	Oligosaccaride compositions and use thereof in the treatment of infection
ES1056525Y (es) *	2004-01-13	2004-07-16	Perez Alfredo Pineiro	Halador de tres rodillos para redes y aparejos de pesca.
PT1629850E (pt) *	2004-08-24	2007-08-14	Nutricia Nv	Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
DE602007006635D1 (en)	2006-02-10	2010-07-01	Nestec Sa	Oligosaccharidmischung
US20110152263A1 (en) *	2006-11-16	2011-06-23	Xi Jiang	Composition and method for inhibiting norovirus infection
US8197872B2 (en) *	2007-05-17	2012-06-12	The Regents Of The University Of California	Human milk oligosaccharides to promote growth of beneficial gut bacteria
EP2185931B1 (en)	2007-09-07	2013-07-10	Children's Hospital Medical Center	Use of secretor, lewis and sialyl antigen levels as predictors for disease
AU2008324105B2 (en) *	2007-11-08	2014-01-30	Société des Produits Nestlé S.A.	Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates
EP2060257A1 (en)	2007-11-08	2009-05-20	Nestec S.A.	Prevention and treatment of secondary infections following viral infection
EP2072052A1 (en) *	2007-12-17	2009-06-24	Nestec S.A.	Prevention of opportunistic infections in immune-compromised subjects
PT2265135T (pt) *	2008-03-14	2018-02-21	Nestec Sa	Mistura simbiótica
JP2012510476A (ja) *	2008-12-02	2012-05-10	プロラクタバイオサイエンス，インコーポレイテッド	ヒト乳透過組成物ならびにその製造および使用方法
WO2010071824A2 (en) *	2008-12-19	2010-06-24	Momenta Pharmaceuticals, Inc.	Methods related to modified glycans
JP5894528B2 (ja)	2009-06-09	2016-03-30	チルドレンズホスピタルメディカルセンター	抗原−ノロウイルスｐドメインモノマーおよびダイマー、抗原−ノロウイルスｐ粒子分子、ならびにそれらの製造および使用法
JP2012532195A (ja)	2009-07-06	2012-12-13	チルドレンズホスピタルメディカルセンター	乳オリゴ糖による炎症の阻害
WO2011008086A1 (en) *	2009-07-15	2011-01-20	N.V. Nutricia	Mixture of non-digestible oligosaccharides for stimulating the immune system
WO2011136637A1 (en)	2010-04-27	2011-11-03	N.V. Nutricia	Use of human milk oligosaccharides in infant nutrition
EP2563166B1 (en)	2010-04-27	2014-05-14	N.V. Nutricia	Use of human milk oligosaccharides in infant nutrition
CA2798675A1 (en) *	2010-06-01	2011-12-08	Glycom A/S	Polymorphs of 2'-o-fucosyllactose and producing thereof
EP2454948A1 (en) *	2010-11-23	2012-05-23	Nestec S.A.	Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465509A1 (en) *	2010-11-23	2012-06-20	Nestec S.A.	Oligosaccharide composition for treating acute respiratory tract infections
WO2012092155A1 (en) *	2010-12-31	2012-07-05	Abbott Laboratories	Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
US8802650B2 (en)	2010-12-31	2014-08-12	Abbott Laboratories	Methods of using human milk oligosaccharides for improving airway respiratory health
MY166945A (en)	2010-12-31	2018-07-25	Abbott Lab	Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
MY191538A (en) *	2010-12-31	2022-06-30	Abbott Lab	Human milk oligosaccharides to promote growth of beneficial bacteria
CA2822490C (en)	2010-12-31	2020-03-31	Abbott Laboratories	Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
ES2804258T3 (es) *	2010-12-31	2021-02-05	Abbott Lab	Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
ES2667393T3 (es)	2010-12-31	2018-05-10	Abbott Laboratories	Oligosacáridos de leche humana para modular inflamación
CN107019701B (zh)	2010-12-31	2020-07-28	雅培制药有限公司	使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
EP2522232A1 (en)	2011-05-13	2012-11-14	Nestec S.A.	Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
EP2707379A4 (en)	2011-05-13	2014-10-08	Glycosyn LLC	USE OF PURIFIED 2'-FUCOSYLLACTOSIS, 3-FUCOSYLLACTOSIS AND LACTODIFUCOTETRAOSE AS PREBIOTICS
EP2526784A1 (en)	2011-05-24	2012-11-28	Nestec S.A.	Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
EP2734210B1 (en) *	2011-07-22	2017-11-22	Abbott Laboratories	Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CA2846603A1 (en) *	2011-08-29	2013-03-07	Abbott Laboratories	Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US9834574B2 (en) *	2012-11-13	2017-12-05	Glycom A/S	Crystalline 3-O-fucosyllactose
WO2014090261A1 (en) *	2012-12-14	2014-06-19	Glycom A/S	Mixture of fucosylate lactoses
EP2745705A1 (en) *	2012-12-18	2014-06-25	Abbott Laboratories	Nutritional use of human milk oligosaccharides
US10626460B2 (en)	2013-02-21	2020-04-21	Children's Hospital Medical Center	Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
US20160113952A1 (en)	2013-05-22	2016-04-28	Glycom As	Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal
US9321803B2 (en)	2013-07-12	2016-04-26	Children's Hospital Medical Center	Compositions and methods for inhibiting norovirus infection
CN105722515A (zh) *	2013-11-15	2016-06-29	雀巢产品技术援助有限公司	用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
SG11201608248YA (en)	2014-04-08	2016-10-28	Abbott Lab	Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
WO2016046294A1 (en) *	2014-09-25	2016-03-31	Nestec S.A.	INFANT FORMULA SYSTEM WITH ADAPTIVE LEVELS OF HUMAN MILK OLIGOSACCHARIDES (HMOs)
WO2016063262A1 (en)	2014-10-24	2016-04-28	Glycom A/S	MIXTURES OF HMOs
CN107105741A (zh)	2014-10-31	2017-08-29	雀巢产品技术援助有限公司	用于促进脑发育和认知的包含fut2‑依赖性低聚糖和乳糖‑n‑新四糖的组合物
MX378680B (es) *	2015-03-05	2025-03-11	Soc Des Produits Nestle S A Star	Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
CN114532538A (zh) *	2015-03-05	2022-05-27	雀巢产品有限公司	用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
WO2016176484A1 (en)	2015-04-28	2016-11-03	Children's Hospital Medical Center	Use of oligosaccharide compositions to enhance weight gain
RU2724590C2 (ru) *	2015-08-04	2020-06-25	Сосьете Де Продюи Нестле С.А.	Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании
EP3389404B1 (en)	2015-12-15	2019-10-02	Société des Produits Nestlé S.A.	Mixture of hmos
CN108495636A (zh) *	2016-01-26	2018-09-04	雀巢产品技术援助有限公司	通过预防过早肥胖反弹而对健康有益的人乳低聚糖
CN119097632A (zh) *	2016-01-26	2024-12-10	雀巢产品有限公司	人乳低聚糖对抗日后的脂肪量过度积聚和相关的健康障碍
KR102593408B1 (ko) *	2016-09-19	2023-10-25	프롤랙타 바이오사이언스, 인코포레이티드	정제된 인간 모유 올리고당 조성물
US20180103675A1 (en)	2016-10-14	2018-04-19	Mead Johnson Nutrition Company	Personalized pediatric nutrition products comprising human milk oligosaccharides
US10980269B2 (en) *	2016-12-12	2021-04-20	Mead Johnson Nutrition Company	Protein hydrolysates and methods of making same
WO2018182983A1 (en)	2017-03-28	2018-10-04	Children's Hospital Medical Center	Norovirus s particle based vaccines and methods of making and using same
CN110769703A (zh)	2017-05-24	2020-02-07	雀巢产品有限公司	用于改善短期记忆和其他认知益处的包含低聚果糖(of)的组合物
WO2018215572A1 (en)	2017-05-24	2018-11-29	Nestec S.A.	Composition comprising human milk oligosaccharides (hmo) for use in the improvement of short term memory and other cognitive benefits
US20200305488A1 (en)	2017-07-07	2020-10-01	Societe Des Produitis Nestle S.A.	Human milk fortifier
US20200221749A1 (en)	2017-07-07	2020-07-16	Societe Des Produits Nestle S.A.	Human milk fortifier
EP3648618A1 (en) *	2017-07-07	2020-05-13	Société des Produits Nestlé S.A.	Human milk fortifier
US11197917B2 (en)	2017-12-01	2021-12-14	ByHeart, Inc.	Formulations for nutritional support in subjects in need thereof
ES3026362T3 (en)	2018-02-08	2025-06-11	Chr Hansen Hmo Gmbh	Spray-dried mixture of human milk oligosaccharides
EP3546060A1 (en) *	2018-03-27	2019-10-02	DuPont Nutrition Biosciences ApS	Process for spray drying fucosyllactose solutions and related product compositions
WO2019160922A1 (en) *	2018-02-19	2019-08-22	Dupont Nutrition Biosciences Aps	Process for spray drying fucosyllactose solutions and related product compositions
WO2020001862A1 (en)	2018-06-25	2020-01-02	Societe Des Produits Nestle S.A.	Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
EP3809879A1 (en)	2018-06-25	2021-04-28	Société des Produits Nestlé S.A.	Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system
WO2020127161A1 (en) *	2018-12-20	2020-06-25	Société des Produits Nestlé S.A.	Human milk fortifier composition
US20220225627A1 (en) *	2019-03-05	2022-07-21	Societe Des Produits Nestle S.A.	A nutritional composition for use to enhance executive function
US20220110985A1 (en) *	2019-06-04	2022-04-14	N.V. Nutricia	Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
WO2021015977A1 (en) *	2019-07-23	2021-01-28	Dupont Nutrition Biosciences Aps	Oral healthcare treatment and related compositions
ES1240969Y (es) *	2019-09-18	2020-07-30	Jennewein Biotechnologie Gmbh	Composiciones de cereales que contienen oligosacaridos de la leche humana
MX2022002949A (es)	2019-09-24	2022-04-06	Prolacta Bioscience Inc	Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes.
GB2590375B (en) *	2019-12-11	2024-05-08	Mjn Us Holdings Llc	Staged nutritional compositions containing human milk oligosaccharides and uses thereof
TW202233201A (zh) *	2020-12-16	2022-09-01	荷蘭商弗里斯蘭康必奶荷蘭有限公司	包含ＬＮＦＰＩＩＩ和ＬＳＴａ的合成組成物
EP4346450B1 (en)	2021-06-04	2025-02-26	N.V. Nutricia	Infant formula for feeding infants receiving infant formula and human breast milk

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5951264B2 (ja) *	1981-11-30	1984-12-13	雪印乳業株式会社	オリゴ糖含有粉末の製造方法
DD273543A3 (de) *	1987-09-14	1989-11-22	Univ Rostock	Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
SE462134B (sv) *	1987-10-22	1990-05-14	Biocarb Ab	Livsmedel innehaallande lacto-n-tetraos och foerfarande foer dess framstaellning
EP0349666B1 (de) *	1988-07-07	1992-12-23	Milupa Aktiengesellschaft	Verfahren zur enzymatischen Herstellung von bifidogener Säuglings- und Diätnahrung
US5095106A (en) *	1989-07-25	1992-03-10	Colgate-Palmolive	Olgiosaccharide inhibition of Streptococcus pyogenes adhesion
WO1991016449A1 (en) *	1990-04-16	1991-10-31	The Trustees Of The University Of Pennsylvania	Saccharide compositions, methods and apparatus for their synthesis
US5021245A (en) *	1990-05-22	1991-06-04	Abbott Laboratories	Infant formula containing a soy polysaccharide fiber source
EP0785988A1 (en) *	1993-07-15	1997-07-30	Neose Pharmaceuticals, Inc	Method of synthesizing saccharide compositions
US5750176A (en) *	1994-03-09	1998-05-12	Abbott Laboratories	Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
JPH0838064A (ja) *	1994-07-26	1996-02-13	Meiji Seika Kaisha Ltd	有害細菌の感染を予防する飼料
US5545553A (en) *	1994-09-26	1996-08-13	The Rockefeller University	Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5827526A (en) *	1995-07-11	1998-10-27	Abbott Laboratories	Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans

1997
- 1997-03-31 US US08/829,157 patent/US6045854A/en not_active Expired - Lifetime
1998
- 1998-03-30 PT PT98912118T patent/PT975235E/pt unknown
- 1998-03-30 EP EP98912118.1A patent/EP0975235B2/en not_active Expired - Lifetime
- 1998-03-30 AT AT98912118T patent/ATE326862T1/de active
- 1998-03-30 DK DK98912118.1T patent/DK0975235T4/da active
- 1998-03-30 CA CA2285065A patent/CA2285065C/en not_active Expired - Lifetime
- 1998-03-30 DE DE69834633.5T patent/DE69834633T3/de not_active Expired - Lifetime
- 1998-03-30 ES ES98912118.1T patent/ES2265161T5/es not_active Expired - Lifetime
- 1998-03-30 JP JP54189298A patent/JP4863236B2/ja not_active Expired - Fee Related
- 1998-03-30 WO PCT/US1998/006216 patent/WO1998043494A1/en not_active Ceased
- 1998-12-18 US US09/216,056 patent/US6146670A/en not_active Expired - Lifetime
1999
- 1999-09-23 NO NO19994621A patent/NO315682B1/no not_active IP Right Cessation
- 1999-09-29 MX MX9908953A patent/MX210206B/es unknown
2011
- 2011-09-07 JP JP2011195159A patent/JP2012036192A/ja active Pending

Also Published As

Publication number	Publication date
JP2012036192A (ja)	2012-02-23
EP0975235B1 (en)	2006-05-24
CA2285065A1 (en)	1998-10-08
WO1998043494A1 (en)	1998-10-08
EP0975235A1 (en)	2000-02-02
DE69834633T3 (de)	2014-05-08
MX210206B (es)	2002-09-06
JP4863236B2 (ja)	2012-01-25
US6045854A (en)	2000-04-04
JP2001517949A (ja)	2001-10-09
DE69834633T2 (de)	2007-05-03
NO994621L (no)	1999-09-23
NO315682B1 (no)	2003-10-13
CA2285065C (en)	2011-07-19
PT975235E (pt)	2006-10-31
ATE326862T1 (de)	2006-06-15
NO994621D0 (no)	1999-09-23
ES2265161T5 (es)	2014-03-24
DE69834633D1 (de)	2006-06-29
DK0975235T4 (da)	2014-03-31
ES2265161T3 (es)	2007-02-01
US6146670A (en)	2000-11-14
MX9908953A (es)	2000-01-31
EP0975235B2 (en)	2014-01-15

Publication	Publication Date	Title
DK0975235T4 (da)	2014-03-31	Ernæringssammensætninger indeholdende oligosaccharider
BG102425A (en)	1999-06-30	(methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
NO20001105L (no)	2000-05-05	Transgene pattedyr som danner oligosakkarider i melken
PE44895A1 (es)	1995-12-20	Compuesto derivado de benzotiofeno que puede inhibir la perdida osea y disminuir el colesterol en suero
BR9611362A (pt)	2001-09-25	Composicões detergentes
IL118047A (en)	2000-11-21	Sulfated oligosaccharides pharmaceutical compositions containing them and preparation of sulfated hexopyranose homooligosaccharides
CA2339765A1 (en)	2000-02-17	Compounds and compositions for delivering active agents
YU23599A (sh)	2001-07-10	Stabilizovani antihistaminski sirup
EP0698031A4 (en)	1997-07-09	SIALYL LE x ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
NO20092860L (no)	2000-01-28	2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
TNSN91070A1 (fr)	1992-10-25	Procede de preparation de derives de benzofuranne, bentothiophene indole ou indolizine ainsi que des compositions les contenant.
MY119388A (en)	2005-05-31	Microemulsion all purpose liquid cleaning compositions
AU571265B2 (en)	1988-04-14	Oxopyrimidine derivatives
HUP9801133A3 (en)	2000-03-28	1,2,4-triazole-derivatives, fungicide compositions containing these compounds as active ingredients
BG103306A (en)	2000-01-31	Liquid allendronate compositions
PT1058544E (pt)	2005-04-29	Inibicao da actividade do tnf
IT9047924A0 (it)	1990-05-08	Composizione per l'igiene orale.
EP1075796A4 (en)	2002-07-17	SWEETENER COMPOSITIONS
TR200002293T2 (tr)	2000-11-21	Farmasötik bileşimler.
ES2183346T3 (es)	2003-03-16	Sistemas conjugados de bis-fosfonato con restos alquilantes que tienen actividad antitumoral.
ES2170377T3 (es)	2002-08-01	Composicion que contiene quitosana.
BG103779A (en)	2000-06-30	Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid
YU23498A (sh)	2001-12-26	Herbicidni 3,5-difluoropiridini
AU7365596A (en)	1997-04-09	Nisin compositions to prevent the promotion of tooth decay bysuppressing formation of acid from foods by oral bacteria
GB2314507A (en)	1998-01-07	Anti-emetic pharmaceutical compositions containing methotrimeprazine